Check back soon for updates on recent transactions and upcoming company growth strategies. Highlights of our company profile include:

Most Recent Transactions - Early Stage and Merchant Banking Group:

We served as placement agent for RespireRx Pharmaceuticals, Inc. (formerly Cortex Pharmaceuticals, Inc.) for an exempt private placement of units comprised of 1 share of common stock and 2 warrants, totaling gross proceeds of $1,195,000.

In addition, we served as placement agent for an exempt private placement offering of 10% Convertible Notes and Warrants totaling $579,500, for RespireRx.

In addition, we served as placement agent for Cortex Pharmaceuticals, Inc. for an exempt private placement of Series G. 1.5% Convertible Stock totaling $928,500 in March and April 2014.

In 2016, we have been providing advice and placement agency services for an ophthalmic company in a proposed strategic financing.

Also in 2016, we provided strategic advice to a microbial detection company, as well as a variety of other investment banking services to life science companies.

Collaboration with HealthCare Capital Advisors:

Since joining Aurora Capital in the second half of 2013, the HealthCare Capital Advisors team has worked closely with the Early Stage and Merchant Banking Division. While the HCCA team has done M&A and public stock transactions prior to joining up with Aurora, they focus on venture capital and private equity financings in the medical device, bio/pharm, and molecular diagnostic spaces, mostly post-angel round financings. HCCA's strengths are its focus and experience in the industry, the professionals' background as analysts on Wall Street, and their client-focused approach. HCCA has relationships with approximately 300+ healthcare venture firms in North America (and several in Europe and Asia) and has a deep understanding of their investment criteria. The HCCA team has worked together since 2001.

Departure of LifeTech Capital Division

On April 1, 2015, our LIfeTech Capital Division terminated their association with Aurora Capital LLC and joined another broker dealer.

General:

Over the past 20 years, Aurora has successfully provided expertise and value added services to the life sciences markets.

Providing quality and focused full-service investment banking, strategic consulting and investment and brokerage services.

Please visit this page in the future for news from Aurora Capital.


Powered by